Measuring a nerve-related eye signal in children on vincristine
Part of Brain & nervous system, Cancer, Pain clinical trials.
This study checks how children’s pupil responses look while they are receiving vincristine (a cancer medicine). The goal is to learn whether a simple eye measurement can reflect how the body is responding to treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 6 and 18 years old when the study starts
- Be receiving vincristine as part of care
- Be able to give consent (or the child can give assent) and agree to join
- Have no serious eye condition that would make eye-pupil testing not possible
- Not be hemodynamically unstable (not in an unsafe/unstable circulation state)
- Not be pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how chemotherapy that can affect nerves (“neurotoxic” chemo) changes nerve function over time. It may help researchers better measure nerve side effects and improve care for people who need these cancer treatments.
This study tests whether shining light on the feet and legs can help reduce nerve damage caused by chemotherapy in people who had cancer as children. If you have ongoing numbness, tingling, or pain in your hands or feet from past chemo, this trial may offer a gentle, drug-free treatment.
This study looks at tiny particles in your blood to understand and potentially predict nerve damage caused by certain chemotherapy drugs. Researchers will monitor you before, during, and after your cancer treatment to see if these particles can help warn doctors about this common side effect.
This study tests a new gel (VMD-3866) applied to the skin to treat moderate nerve pain, numbness, or tingling caused by previous chemotherapy. It aims to see if the gel can safely reduce pain for people whose symptoms have been stable for at least 8 weeks.
This study tests whether remote check-ins (via phone/app/website) can help manage chemotherapy-related nerve pain in the hands and feet. It enrolls adults who developed nerve symptoms after certain cancer medicines and need ongoing monitoring.
This test uses a light device (photobiomodulation) to see if it can help prevent or reduce nerve damage and pain caused by chemotherapy. It is for patients starting cancer treatment.
Hear when a new Chemotherapy-induced Peripheral Neuropathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.